Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Amedisys Q2 Adj EPS $1.37 Beats $1.09 Estimate, Sales $553.00M Miss $568.20M Estimate

Author: Benzinga Newsdesk | July 26, 2023 04:36pm

Amedisys (NASDAQ:AMED) reported quarterly adj earnings of $1.37 per share which beat the analyst consensus estimate of $1.09 by 25.69 percent. This is a 6.8 percent decrease over earnings of $1.47 per share from the same period last year. The company reported quarterly sales of $553.00 million which missed the analyst consensus estimate of $568.20 million by 2.68 percent. This is a 0.88 percent decrease over sales of $557.89 million the same period last year.

Posted In: AMED


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist